Latest Commercialisation News

Elixir Energy has secured $5 million through a discounted placement to support ongoing flow tests at Lorelle-3H, artificial lift trials at Diona-1, and initiate a strategic review of its Taroom Trough assets.

Anteris Technologies posted a $51.7 million loss in H1 2026 amid ramped-up R&D and clinical trial activity, supported by a $320 million capital raise and Medicare reimbursement for its DurAVR heart valve trial.

EBR Systems marked a commercial milestone with over 100 WiSE CRT implants and secured purchasing agreements with three major US healthcare networks. The company is progressing toward Medicare coverage and scaling manufacturing, supported by a near-complete A$150 million capital raise.

Sprintex has inked a co-development deal with Jiangsu Bosiwei to supply its 30kW MVR compressors for a major retrofit at Hebei Yufeng Group, marking its strategic entry into China’s booming industrial vapor compression market.

Black Canyon has confirmed a 400-metre southern extension to its Wandanya manganese project, delivering multiple high-grade manganese intercepts and advancing towards a maiden Mineral Resource Estimate in September 2026.

Metallium Limited has demonstrated its Flash Joule Heating technology can process a broad range of critical metal feedstocks, from rare earth ores to industrial wastes, opening new commercial pathways beyond electronic waste.

EV Resources has locked in 200 tonnes of premium antimony ore near its Tecomatlán plant, setting the stage for its first commercial processing campaign under a five-year supply deal.

Australian Rare Earths (ASX: AR3) has successfully commissioned and begun pilot-scale processing of 30 tonnes of ore at ANSTO’s Sydney facility, producing high-purity rare earth oxide samples to support commercialisation and a bankable feasibility study.

Sparc Hydrogen has partnered with US-based SunHydrogen to integrate and test solar-driven green hydrogen modules, hitting a notable 10% solar-to-hydrogen efficiency in early trials. This collaboration aims to advance pilot-scale testing and techno-economic analysis to lower hydrogen production costs.

Blue Star Helium has delivered its third helium trailer from the Pinon Canyon Plant, signalling steady progress toward full production capacity. A fourth trailer is currently being filled as the company pursues further plant optimisation and commercialisation of CO2 byproduct.

Lithium Universe Limited (ASX: LU7) has reported laboratory success for its licensed GCDE technology, achieving over 99% gold recovery and 97% purity from chloride solutions and e-waste, positioning it as a greener alternative in precious metals extraction.

LTR Pharma reports a 93% response rate in men seeking convenience and spontaneity with SPONTAN, alongside a 64% response in post-prostatectomy patients, highlighting potential for its rapid-onset intranasal ED treatment in challenging populations.